![Nir Naor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nir Naor
Directeur/Bestuurslid bij
BRAINSTORM CELL THERAPEUTICS INC.
Vermogen: 23 599 $ op 31-05-2026
Profiel
Nir Naor is an Independent Director at Brainstorm Cell Therapeutics, Inc. since 2023.
Former positions include Chief Financial Officer at Axogen, Inc. from 2023 to 2025, Chief Financial Officer at QuVa Pharma, Inc. in 2023, Chief Financial Officer at HMNC Holding GmbH from 2021 to 2022, Chief Financial Officer at Arbor Pharmaceuticals, Inc. in 2021, Chief Financial Officer-US Americas at Molnlycke Health Care US LLC from 2017 to 2021, Chief Financial Officer-United States at UCB SA from 2012 to 2017, and Auditor at KPMG Corporate Finance LLC from 2001 to 2005.
Education includes undergraduate, graduate, and MBA degrees from Tel-Aviv University, a graduate degree from the University of Hamburg, and an MBA from the International Institute for Management Development.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-02-2026 | 31.465 ( 0,29% ) | 23 599 $ | 31-05-2026 |
Actieve functies van Nir Naor
| Bedrijven | Functie | Begin |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur/Bestuurslid | 20-06-2023 |
Eerdere bekende functies van Nir Naor
| Bedrijven | Functie | Einde |
|---|---|---|
| AXOGEN, INC. | Financieel Directeur/CFO | 11-05-2025 |
QuVa Pharma, Inc.
 QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Financieel Directeur/CFO | 01-09-2023 |
HMNC Holding GmbH
 HMNC Holding GmbH Financial ConglomeratesFinance Provides investment services | Financieel Directeur/CFO | 01-10-2022 |
Arbor Pharmaceuticals, Inc.
 Arbor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on neuroscience, cardiovascular and pediatric markets | Financieel Directeur/CFO | 01-09-2021 |
Molnlycke Health Care US LLC
 Molnlycke Health Care US LLC Medical SpecialtiesHealth Technology Manufactures surgical and wound care products | Corporate Officer/Principal | 01-01-2021 |
Opleiding van Nir Naor
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
KPMG Corporate Finance LLC
 KPMG Corporate Finance LLC Investment ManagersFinance Provides investment advice | Finance |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hamburg
 University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molnlycke Health Care US LLC
Molnlycke Health Care US LLC Medical SpecialtiesHealth Technology Manufactures surgical and wound care products | Health Technology |
Axogen, Inc.
 Axogen, Inc. Medical SpecialtiesHealth Technology Provides products and technologies for peripheral nerve reconstruction and regeneration | Health Technology |
QuVa Pharma, Inc.
QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Health Technology |
Arbor Pharmaceuticals, Inc.
Arbor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on neuroscience, cardiovascular and pediatric markets | Health Technology |
HMNC Holding GmbH
HMNC Holding GmbH Financial ConglomeratesFinance Provides investment services | Finance |
Kies MarketScreener 
